$4.76 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 133 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEOS | Exit | NEOS THERAPEUTICS INC | $0 | – | -320,993 | -100.0% | -0.00% | – |
| FUSN | Exit | FUSION PHARMACEUTICALS INC | $0 | – | -162,378 | -100.0% | -0.04% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -64,946 | -100.0% | -0.04% | – |
| MASS | Exit | 908 DEVICES INC | $0 | – | -75,000 | -100.0% | -0.08% | – |
| LGVWWS | Exit | LONGVIEW ACQUISITION CORP*w exp 05/27/202 | $0 | – | -733,333 | -100.0% | -0.10% | – |
| EAR | Exit | EARGO INC | $0 | – | -125,000 | -100.0% | -0.11% | – |
| Exit | BENEFITFOCUS INCnote 1.250%12/1 | $0 | – | -6,500,000 | -100.0% | -0.11% | – | |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -385,043 | -100.0% | -0.13% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -75,000 | -100.0% | -0.13% | – |
| PANAU | Exit | PANACEA ACQUISITION CORPunit 99/99/9999 | $0 | – | -500,000 | -100.0% | -0.13% | – |
| TSHA | Exit | TAYSHA GENE THERAPIES INC | $0 | – | -250,000 | -100.0% | -0.13% | – |
| SIEN | Exit | SIENTRA INC | $0 | – | -1,918,118 | -100.0% | -0.15% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -175,000 | -100.0% | -0.20% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -800,000 | -100.0% | -0.22% | – |
| SRRK | Exit | SCHOLAR ROCK HLDG CORP | $0 | – | -288,876 | -100.0% | -0.28% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -163,000 | -100.0% | -0.28% | – |
| CDAK | Exit | CODIAK BIOSCIENCES INC | $0 | – | -450,000 | -100.0% | -0.29% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -407,000 | -100.0% | -0.29% | – |
| SEM | Exit | SELECT MED HLDGS CORP | $0 | – | -565,000 | -100.0% | -0.31% | – |
| VAPO | Exit | VAPOTHERM INC | $0 | – | -604,520 | -100.0% | -0.32% | – |
| ALGS | Exit | ALIGOS THERAPEUTICS INC | $0 | – | -600,000 | -100.0% | -0.33% | – |
| OXFD | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -1,049,035 | -100.0% | -0.36% | – |
| TARA | Exit | PROTARA THERAPEUTICS INC | $0 | – | -782,670 | -100.0% | -0.37% | – |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -350,000 | -100.0% | -0.38% | – |
| OSUR | Exit | ORASURE TECHNOLOGIES INC | $0 | – | -2,124,515 | -100.0% | -0.44% | – |
| Exit | PACIRA BIOSCIENCES INCnote 2.375% 4/0 | $0 | – | -20,000,000 | -100.0% | -0.45% | – | |
| ACCD | Exit | ACCOLADE INC | $0 | – | -638,001 | -100.0% | -0.55% | – |
| STTK | Exit | SHATTUCK LABS INC | $0 | – | -550,000 | -100.0% | -0.57% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -202,406 | -100.0% | -0.59% | – |
| Exit | NOVAVAX INCnote 3.750% 2/0 | $0 | – | -25,000,000 | -100.0% | -0.62% | – | |
| NUVA | Exit | NUVASIVE INC | $0 | – | -565,000 | -100.0% | -0.63% | – |
| EDIT | Exit | EDITAS MEDICINE INC | $0 | – | -538,721 | -100.0% | -0.75% | – |
| QDEL | Exit | QUIDEL CORP | $0 | – | -220,000 | -100.0% | -0.78% | – |
| AXNX | Exit | AXONICS MODULATION TECHNOLOG | $0 | – | -800,000 | -100.0% | -0.79% | – |
| Exit | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $0 | – | -49,064,000 | -100.0% | -0.89% | – | |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -405,386 | -100.0% | -0.90% | – |
| Exit | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $0 | – | -57,791,000 | -100.0% | -0.90% | – | |
| DFHTU | Exit | DEERFIELD HEALTHCARE TECH ACunit 07/16/2025 | $0 | – | -3,360,000 | -100.0% | -1.00% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -564,067 | -100.0% | -1.01% | – |
| DFPHU | Exit | DFP HEALTHCARE ACQUISITNS COunit 03/31/2025 | $0 | – | -5,000,000 | -100.0% | -1.11% | – |
| OSH | Exit | OAK STR HEALTH INC | $0 | – | -951,063 | -100.0% | -1.15% | – |
| Exit | INSMED INCnote 1.750% 1/1 | $0 | – | -61,000,000 | -100.0% | -1.37% | – | |
| Exit | INSULET CORPnote 0.375% 9/0 | $0 | – | -57,581,000 | -100.0% | -1.51% | – | |
| NKTX | Exit | NKARTA INC | $0 | – | -1,419,872 | -100.0% | -1.72% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -579,248 | -100.0% | -1.79% | – |
| Exit | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $0 | – | -54,825,000 | -100.0% | -1.83% | – | |
| Exit | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $0 | – | -149,600,000 | -100.0% | -2.71% | – | |
| Exit | NUVASIVE INCnote 2.250% 3/1 | $0 | – | -200,000,000 | -100.0% | -3.98% | – | |
| Exit | INVITAE CORPnote 2.000% 9/0 | $0 | – | -163,385,000 | -100.0% | -5.22% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.